Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hypogonadism Clinical Trials

A listing of Hypogonadism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (12) clinical trials

We are currently seeking male volunteers, who have low testosterone levels. This is a study of an oral investigational medication that may increase testosterone levels. All participants will receive the investigational medication and must be willing to take the medication twice a day. Participants currently being treated with testosterone will ...

Phase

Testosterone replacement therapy in adult, 18 years or older, males for conditions associated with a deficiency or absence of endogenous testosterone – primary hypogonadism (congenital or acquired) or secondary hypogonadism (congenital or acquired).

Phase

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

The study will be conducted in male subjects from 18 to 80 years of age requiring testosterone replacement therapy for primary or secondary hypogonadism. The study is a randomised, active control, single dose, 2-way cross-over study in 2 cohorts. In each cohort subjects who meet the entry criteria at screening ...

Phase

Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC

Eligible subjects will receive pembrolizumab beginning on Day 1 of each 3-week dosing cycle (d1, qd22) together with maraviroc administered perorally on day 1 to 21 of each cycle (d1-21; qd22). Treatment with pembrolizumab / maraviroc combination will continue until progressive disease (PD), unacceptable adverse events (AEs), intercurrent illness that ...

Phase

Kisspeptin Influence on Glucose Homeostasis

This study examines how a naturally occurring peptide called Kisspeptin might regulate blood sugar and insulin levels.

Phase

Testosterone Replacement in Renal Failure

Testosterone replacement can increase hemoglobin count. This can therefore decrease the requirement of Erythropoietin Stimulating agents.

Phase

Evaluation of Testosterone Nasal Gel in Hypogonadal Boys

ARM 1 - 10 subjects at Tanner Stage 0 boys with bone age >/= 10.5 will receive single dose of 5.5mg on day one and single dose of 11mg on day 2 with repeat blood draws to assess serum levels of testosterone and metabolites. ARM 2 - 10 subjects with ...

Phase

Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.

Phase

Administration of Kisspeptin to Subjects With Reproductive Disorders

The master reproductive hormone GnRH (gonadotropin-releasing hormone) is essential for normal reproductive function. People with hypogonadotropic hypogonadism (IHH), hyperprolactinemia, and polycystic ovarian syndrome (PCOS) do not secrete or respond to GnRH in a normal way. In this study, investigators will give participants, kisspeptin a hormone that is naturally found in ...

Phase

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Please contact study staff for a detailed description.

Phase